Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.
|
Surgery
|
1994
|
4.16
|
2
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
J Am Coll Surg
|
1998
|
2.31
|
3
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Transplantation
|
1995
|
2.09
|
4
|
Delayed graft function in the kidney transplant.
|
Am J Transplant
|
2011
|
2.06
|
5
|
Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.
|
Ann Surg
|
1998
|
1.72
|
6
|
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
|
Transplantation
|
1999
|
1.62
|
7
|
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.
|
Transplantation
|
1995
|
1.59
|
8
|
Weaning of immunosuppression in liver transplant recipients.
|
Transplantation
|
1997
|
1.57
|
9
|
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
|
Aliment Pharmacol Ther
|
2008
|
1.32
|
10
|
Current status of intestinal transplantation in children.
|
J Pediatr Surg
|
1998
|
1.28
|
11
|
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
|
Transplantation
|
1998
|
1.28
|
12
|
Infectious complications after small bowel transplantation in adults.
|
Transplant Proc
|
1994
|
1.24
|
13
|
Response to interferon alpha therapy is influenced by the iron content of the liver.
|
J Hepatol
|
1994
|
1.21
|
14
|
Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients.
|
Transplantation
|
1999
|
1.19
|
15
|
Tacrolimus in pediatric renal transplantation.
|
Transplantation
|
1996
|
1.18
|
16
|
Adverse effects of FK 506 overdosage after liver transplantation.
|
Transplant Proc
|
1993
|
1.18
|
17
|
Disease gravity and urgency of need as guidelines for liver allocation.
|
Hepatology
|
1994
|
1.16
|
18
|
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.
|
Am J Gastroenterol
|
1995
|
1.16
|
19
|
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.
|
Clin Transplant
|
1994
|
1.15
|
20
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Transplantation
|
1999
|
1.14
|
21
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Transplant Proc
|
1995
|
1.13
|
22
|
Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation.
|
J Infect Dis
|
1992
|
1.12
|
23
|
FK506 in pediatric kidney transplantation--primary and rescue experience.
|
Pediatr Nephrol
|
1995
|
1.11
|
24
|
Tacrolimus in renal transplantation.
|
Transplant Proc
|
1996
|
1.10
|
25
|
Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD.
|
Am J Kidney Dis
|
1997
|
1.08
|
26
|
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.
|
Am J Gastroenterol
|
1995
|
1.05
|
27
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Transplantation
|
1999
|
1.00
|
28
|
Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.
|
Transplantation
|
1995
|
0.99
|
29
|
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
|
Transplantation
|
1994
|
0.98
|
30
|
Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
|
Am J Transplant
|
2012
|
0.97
|
31
|
Predictive ability of pretransplant comorbidities to predict long-term graft loss and death.
|
Am J Transplant
|
2008
|
0.97
|
32
|
Gastrointestinal bleeding after liver transplantation.
|
Transplantation
|
1997
|
0.96
|
33
|
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.
|
Ann Surg
|
1996
|
0.96
|
34
|
Can adenine nucleotides predict primary nonfunction of the human liver homograft?
|
Transpl Int
|
1994
|
0.95
|
35
|
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation.
|
Transplant Proc
|
1994
|
0.94
|
36
|
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.
|
Transplant Proc
|
1995
|
0.94
|
37
|
The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center.
|
Medicine (Baltimore)
|
2001
|
0.93
|
38
|
A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients.
|
Transplantation
|
1994
|
0.93
|
39
|
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.
|
Transplant Proc
|
1991
|
0.93
|
40
|
Cytomegalovirus infection after intestinal transplantation in children.
|
Clin Infect Dis
|
1997
|
0.93
|
41
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplant Proc
|
1998
|
0.91
|
42
|
Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation.
|
Transplant Proc
|
1993
|
0.89
|
43
|
Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors.
|
Am J Transplant
|
2007
|
0.87
|
44
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Liver Transpl Surg
|
1998
|
0.86
|
45
|
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
|
Dig Dis Sci
|
1998
|
0.86
|
46
|
Pediatric kidney transplantation at the University of Pittsburgh.
|
Transplant Proc
|
1994
|
0.86
|
47
|
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients.
|
Liver Transpl Surg
|
1996
|
0.85
|
48
|
The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation.
|
Transfusion
|
1993
|
0.83
|
49
|
Recent advances in hepatic transplantation at the University of Pittsburgh.
|
Clin Transpl
|
1993
|
0.83
|
50
|
Renal transplantation under FK 506 in African-Americans: early experience.
|
Transplant Proc
|
1993
|
0.83
|
51
|
Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study.
|
HIV Med
|
2005
|
0.83
|
52
|
Renal transplantation in recipients over the age of 60: the impact of donor age.
|
Transplantation
|
1999
|
0.82
|
53
|
Improving results of pediatric renal transplantation.
|
J Am Coll Surg
|
1994
|
0.82
|
54
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Transplantation
|
1996
|
0.82
|
55
|
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
|
Transplant Proc
|
1991
|
0.81
|
56
|
Long-term experience with everolimus in kidney transplantation in the United States.
|
Transplant Proc
|
2011
|
0.81
|
57
|
Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis.
|
Ther Drug Monit
|
1996
|
0.80
|
58
|
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.
|
Transplant Proc
|
1995
|
0.80
|
59
|
Infectious complications after small bowel transplantation in adults: an update.
|
Transplant Proc
|
1996
|
0.80
|
60
|
Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.
|
Transplant Proc
|
1995
|
0.79
|
61
|
Evaluating glioma therapies: modeling treatments and predicting outcomes.
|
J Natl Cancer Inst
|
1995
|
0.79
|
62
|
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.
|
Transplant Proc
|
1992
|
0.79
|
63
|
Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test.
|
J Hepatol
|
1993
|
0.78
|
64
|
gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.
|
Hepatogastroenterology
|
1996
|
0.77
|
65
|
Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy.
|
Ann N Y Acad Sci
|
1993
|
0.77
|
66
|
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
|
Transplant Proc
|
1995
|
0.76
|
67
|
Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.
|
Transplant Proc
|
1999
|
0.76
|
68
|
Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation.
|
Transplantation
|
1993
|
0.75
|
69
|
Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh.
|
Transplant Proc
|
1993
|
0.75
|
70
|
Outcome of kidney transplantation in African-Americans using tacrolimus.
|
Transplant Proc
|
1997
|
0.75
|
71
|
Influence of donor criteria on early outcome after intestinal transplantation.
|
Transplant Proc
|
1997
|
0.75
|
72
|
Posttransplant hypertension in blacks versus nonblacks.
|
Transplant Proc
|
1993
|
0.75
|
73
|
Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates.
|
Alcohol Clin Exp Res
|
2000
|
0.75
|
74
|
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.
|
Autoimmunity
|
1994
|
0.75
|
75
|
Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation.
|
Transplant Proc
|
1994
|
0.75
|
76
|
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
|
Transplant Proc
|
1995
|
0.75
|
77
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
J Urol
|
1998
|
0.75
|
78
|
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts.
|
Transplant Proc
|
1993
|
0.75
|
79
|
Outcome of liver transplantation in critically ill patients with alcoholic cirrhosis: survival according to medical variables and sobriety.
|
Transplantation
|
1998
|
0.75
|
80
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Transplant Proc
|
1999
|
0.75
|